Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS? - PubMed
2 hours ago
- #Multiple Sclerosis
- #Medical Research
- #Drug Safety
- The article questions whether Roche's drug Ocrevus might be more harmful than beneficial for women with primary progressive multiple sclerosis.
- It includes a PMID (41985930) and DOI (10.1136/bmj.s666) for reference.
- A conflict of interest statement directs readers to detailed competing interests information on the BMJ website.